176 related articles for article (PubMed ID: 22418244)
1. Expression of heme oxygenase-1 in non-small cell lung cancer (NSCLC) and its correlation with clinical data.
Degese MS; Mendizabal JE; Gandini NA; Gutkind JS; Molinolo A; Hewitt SM; Curino AC; Coso OA; Facchinetti MM
Lung Cancer; 2012 Jul; 77(1):168-75. PubMed ID: 22418244
[TBL] [Abstract][Full Text] [Related]
2. High expression of heme oxygenase-1 is associated with tumor invasiveness and poor clinical outcome in non-small cell lung cancer patients.
Tsai JR; Wang HM; Liu PL; Chen YH; Yang MC; Chou SH; Cheng YJ; Yin WH; Hwang JJ; Chong IW
Cell Oncol (Dordr); 2012 Dec; 35(6):461-71. PubMed ID: 23055342
[TBL] [Abstract][Full Text] [Related]
3. Decreased heme-oxygenase (HO)-1 in the macrophages of non-small cell lung cancer.
Boschetto P; Zeni E; Mazzetti L; Miotto D; Lo Cascio N; Maestrelli P; Marian E; Querzoli P; Pedriali M; Murer B; De Rosa E; Fabbri LM; Mapp CE
Lung Cancer; 2008 Feb; 59(2):192-7. PubMed ID: 17900753
[TBL] [Abstract][Full Text] [Related]
4. Expression of TAK1/TAB1 expression in non-small cell lung carcinoma and adjacent normal tissues and their clinical significance.
Zhu J; Li Q; He JT; Liu GY
Int J Clin Exp Pathol; 2015; 8(12):15801-7. PubMed ID: 26884850
[TBL] [Abstract][Full Text] [Related]
5. Correlations of lysyl oxidase with MMP2/MMP9 expression and its prognostic value in non-small cell lung cancer.
Liu J; Ping W; Zu Y; Sun W
Int J Clin Exp Pathol; 2014; 7(9):6040-7. PubMed ID: 25337249
[TBL] [Abstract][Full Text] [Related]
6. Regulation and novel action of thymidine phosphorylase in non-small cell lung cancer: crosstalk with Nrf2 and HO-1.
Tertil M; Skrzypek K; Florczyk U; Weglarczyk K; Was H; Collet G; Guichard A; Gil T; Kuzdzal J; Jozkowicz A; Kieda C; Pichon C; Dulak J
PLoS One; 2014; 9(5):e97070. PubMed ID: 24819505
[TBL] [Abstract][Full Text] [Related]
7. Nrf2-heme oxygenase-1 axis in mucoepidermoid carcinoma of the lung: Antitumoral effects associated with down-regulation of matrix metalloproteinases.
Tertil M; Golda S; Skrzypek K; Florczyk U; Weglarczyk K; Kotlinowski J; Maleszewska M; Czauderna S; Pichon C; Kieda C; Jozkowicz A; Dulak J
Free Radic Biol Med; 2015 Dec; 89():147-57. PubMed ID: 26393425
[TBL] [Abstract][Full Text] [Related]
8. Nuclear localization of heme oxygenase-1 is associated with tumor progression of head and neck squamous cell carcinomas.
Gandini NA; Fermento ME; Salomón DG; Blasco J; Patel V; Gutkind JS; Molinolo AA; Facchinetti MM; Curino AC
Exp Mol Pathol; 2012 Oct; 93(2):237-45. PubMed ID: 22580187
[TBL] [Abstract][Full Text] [Related]
9. A novel experimental heme oxygenase-1-targeted therapy for hormone-refractory prostate cancer.
Alaoui-Jamali MA; Bismar TA; Gupta A; Szarek WA; Su J; Song W; Xu Y; Xu B; Liu G; Vlahakis JZ; Roman G; Jiao J; Schipper HM
Cancer Res; 2009 Oct; 69(20):8017-24. PubMed ID: 19808972
[TBL] [Abstract][Full Text] [Related]
10. B3GNT3 overexpression is associated with unfavourable survival in non-small cell lung cancer.
Gao L; Zhang H; Zhang B; Zhu J; Chen C; Liu W
J Clin Pathol; 2018 Jul; 71(7):642-647. PubMed ID: 29483137
[TBL] [Abstract][Full Text] [Related]
11. CCL21/CCR7 up-regulate vascular endothelial growth factor-D expression via ERK pathway in human non-small cell lung cancer cells.
Sun L; Zhang Q; Li Y; Tang N; Qiu X
Int J Clin Exp Pathol; 2015; 8(12):15729-38. PubMed ID: 26884842
[TBL] [Abstract][Full Text] [Related]
12. Expression of miR-32 in human non-small cell lung cancer and its correlation with tumor progression and patient survival.
Bai Y; Wang YL; Yao WJ; Guo L; Xi HF; Li SY; Zhao BS
Int J Clin Exp Pathol; 2015; 8(1):824-9. PubMed ID: 25755781
[TBL] [Abstract][Full Text] [Related]
13. Down-regulation of microRNA-181b is a potential prognostic marker of non-small cell lung cancer.
Yang J; Liu H; Wang H; Sun Y
Pathol Res Pract; 2013 Aug; 209(8):490-4. PubMed ID: 23827213
[TBL] [Abstract][Full Text] [Related]
14. Metformin Sensitizes Non-small Cell Lung Cancer Cells to an Epigallocatechin-3-Gallate (EGCG) Treatment by Suppressing the Nrf2/HO-1 Signaling Pathway.
Yu C; Jiao Y; Xue J; Zhang Q; Yang H; Xing L; Chen G; Wu J; Zhang S; Zhu W; Cao J
Int J Biol Sci; 2017; 13(12):1560-1569. PubMed ID: 29230104
[TBL] [Abstract][Full Text] [Related]
15. Down-regulation of microRNA-126 and microRNA-133b acts as novel predictor biomarkers in progression and metastasis of non small cell lung cancer.
Chen SW; Wang TB; Tian YH; Zheng YG
Int J Clin Exp Pathol; 2015; 8(11):14983-8. PubMed ID: 26823832
[TBL] [Abstract][Full Text] [Related]
16. Increased expression of the lncRNA PVT1 promotes tumorigenesis in non-small cell lung cancer.
Yang YR; Zang SZ; Zhong CL; Li YX; Zhao SS; Feng XJ
Int J Clin Exp Pathol; 2014; 7(10):6929-35. PubMed ID: 25400777
[TBL] [Abstract][Full Text] [Related]
17. Resveratrol inhibits human lung adenocarcinoma cell metastasis by suppressing heme oxygenase 1-mediated nuclear factor-kappaB pathway and subsequently downregulating expression of matrix metalloproteinases.
Liu PL; Tsai JR; Charles AL; Hwang JJ; Chou SH; Ping YH; Lin FY; Chen YL; Hung CY; Chen WC; Chen YH; Chong IW
Mol Nutr Food Res; 2010 Jul; 54 Suppl 2():S196-204. PubMed ID: 20461740
[TBL] [Abstract][Full Text] [Related]
18. Overexpression of EI2BL promoted human non-small cell lung cancer progression by inducing cell EMT phenotype.
Li HR; Qiu BQ; Gao J; Jin C; Jiang JH; Ding JY
J Clin Pathol; 2020 Mar; 73(3):139-146. PubMed ID: 31586937
[TBL] [Abstract][Full Text] [Related]
19. High TBX2 expression predicts poor prognosis in non-small cell lung cancer.
Zhang Z; Guo Y
Neoplasma; 2014; 61(4):476-80. PubMed ID: 25027744
[TBL] [Abstract][Full Text] [Related]
20. [Effects of heme oxygenase-1 knockdown on proliferation, invasion and metastasis of lung adenocarcinoma A549 cells and its mechanism].
Cao L; Suo XJ; Jiang W; Zhao D; Yan XJ; Yang J; Ma ZY
Zhonghua Zhong Liu Za Zhi; 2019 Nov; 41(11):813-819. PubMed ID: 31770847
[No Abstract] [Full Text] [Related]
[Next] [New Search]